Evidence map›Paper›PMID 28941536›Full record

ReviewPediatric clinics of North America2017

Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Bradley S Podd, Dennis W Simon, Santiago Lopez, Andrew Nowalk, Rajesh Aneja, Joseph A Carcillo

Abstract readReview
In one paragraph

Review in Pediatric clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A Multicenter Network Assessment of Three Inflammation Phenotypes in Pediatric Sepsis-Induced Multiple Organ Failure.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2019
    Article
  6. Article
  7. Review
  8. Understanding Disseminated Intravascular Coagulation and Hepatobiliary Dysfunction Multiple Organ Failure in Hyperferritinemic Critical Illness.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2018
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bradley S PoddDepartment of Critical Care Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA.
Dennis W SimonDepartment of Critical Care Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA.
Santiago LopezDepartment of Pediatrics, Division of Infectious Diseases, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA.
Andrew NowalkDepartment of Pediatrics, Division of Infectious Diseases, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA.
Rajesh AnejaDepartment of Critical Care Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA.
Joseph A CarcilloDepartment of Critical Care Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, 4400 Penn Avenue, Pittsburgh, PA 15214, USA. Electronic address: carcilloja@ccm.upmc.edu.

Funding

Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure RenewalR01GM108618 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOSEPH A CARCILLO · 2014 to 2026
$5.4M
Renewal Application for the Childrens Hospital of Pittsburgh Collaborative Pediatric Critical Care Research Network SiteUG1HD049983 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARCILLO, JOSEPH A · 2015 to 2020
$1.6M
NICHD NIH HHS UG1 HD049983NIGMS NIH HHS R01 GM108618
6 · The paper itself

Abstract

Adjunctive therapies have been proposed for use in at least 5 inflammation pathobiology phenotypes in pediatric sepsis-induced multiple organ failure. This article discusses host-pathogen interaction prototypes to facilitate understanding of the rationale for personalized therapy in these phenotypes. The article discusses the literature on adjunctive antiinflammatory and immune modulation therapies that, in addition to traditional organ support and infection source control, might be part of a personalized precision medicine approach to the reversal of each of these inflammatory pathobiology phenotypes.

Indexed as

ChildCombined Modality TherapyCritical CareHumansMultiple Organ FailurePrecision MedicineSepsisHyperleukocytosisImmune paralysisMacrophage activation syndromeSequential MOFThrombocytopenia-associated MOF

Identifiers

PMID28941536
PMCPMC5663307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.